 |
|
Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension
Young Ho Lee, Gwan Gyu Song
Korean J Intern Med. 2013;28(6):701-707. Published online 2013 Oct 29 DOI: https://doi.org/10.3904/kjim.2013.28.6.701
|
|
Citations to this article as recorded by
 Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis
Fen Cao, Kun Wu, Yong-zhi Zhu, Jun-jun Jiang, Gui Zhang, Jun Liu, Ping Xiao, Yang Tian, Wei Zhang, Sheng Zhang, Feng Hou, Zhong-wu Bao
Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model
L. Englert, C. Stadlbauer, M. Spaeth, H.S. Hofmann, C. Schneider, R.A. Hatz, G. Preissler, S. Michel, S. Golovchenko, M. Ried, M. Hoenicka
Pulmonary Pharmacology & Therapeutics.2021; 66: 101985. CrossRef Chronic thromboembolic pulmonary hypertension: a review
CZ Chong, ELW Tay, CH Sia, KK Poh
Singapore Medical Journal.2021; : 318. CrossRef Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?
Jordy M. M. Kocken, Paula A. da Costa Martins
International Journal of Molecular Sciences.2020; 21(23): 8901. CrossRef Diagnosis of Pulmonary Arterial Hypertension in Children by Using Cardiac Computed Tomography
Shyh-Jye Chen, Jou-Hsuan Huang, Wen-Jeng Lee, Ming-Tai Lin, Yih-Sharng Chen, Jou-Kou Wang
Korean Journal of Radiology.2019; 20(6): 976. CrossRef Efficacy and tolerability of pharmacological interventions for pulmonary arterial hypertension: A network meta-analysis
Hongjing Lin, Mupeng Wang, Ying Yu, Zeyu Qin, Xin Zhong, Jiahui Ma, Fangbo Zhao, Xueli Zhang
Pulmonary Pharmacology & Therapeutics.2018; 50: 1. CrossRef Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta‐analysis
Xinwang Chen, Zhenguo Zhai, Ke Huang, Wanmu Xie, Jun Wan, Chen Wang
The Clinical Respiratory Journal.2018; 12(6): 2065. CrossRef Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis
Mi-Ma Duo-Ji, Zi-Wen Long
International Journal of Cardiology.2017; 234: 90. CrossRef Medikamente bei pulmonal-arterieller Hypertonie
Urspeter Masche
pharma-kritik.2017;[Epub] CrossRef Comparative Effectiveness of Oral Medications for Pulmonary Arterial Hypertension
Ataru Igarashi, Sachie Inoue, Tomonori Ishii, Kiichiro Tsutani, Hiroshi Watanabe
International Heart Journal.2016; 57(4): 466. CrossRef Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1
William H. Nugent, Nikita Mishra, Jerome F. Strauss, Scott W. Walsh
Reproductive Sciences.2016; 23(4): 542. CrossRef Endothelin Blockade in Diabetic Kidney Disease
Lidia Anguiano, Marta Riera, Julio Pascual, María Soler
Journal of Clinical Medicine.2015; 4(6): 1171. CrossRef Drug-induced liver injury: what was new in 2013?
Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis
Expert Opinion on Drug Metabolism & Toxicology.2014; 10(7): 959. CrossRef
|